Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Verily Life Sciences

- PMLiVE

Rosalind Franklin Institute invests £6m in disruptive technologies

Will open new AI-enabled research facility based in the UK

- PMLiVE

NICE backs Tesaro’s Zejula via the CDF

Recommends the drug for second-line use in ovarian cancer patients

Global mHealth market predicted to reach $58.8bn by 2020

And digital therapeutics could rival mainstream pharmaceutical products, according to a report

- PMLiVE

Digital skills gap hinders UK healthcare innovation

Report calls for greater emphasis on HCPs’ digital and data literacy education

Boehringer Ingelheim headquarters

Boehringer partners with Bactevo on drug discovery

Bactevo will use its TIME platform to identify small molecule lead compounds

Boehringer partners with Bactevo on drug discovery

Bactevo will use its TIME platform to identify small molecule lead compounds

- PMLiVE

NHS England pledges to streamline clinical trial setup

The process will also target the procedure for reimbursements in additional treatment costs

- PMLiVE

Daily Brief: Deal done, Takeda to cut $1.4bn, Brexit latest, Valeant rebrands

A rapid round-up of the top pharma, biotech and healthcare news

- PMLiVE

FDA looks to regulate digital tools

US regulator adds new components to digital health plan

- PMLiVE

Disruptive technologies set to stabilise soaring drug prices

AI and blockchain could accelerate the drug development process, says report

- PMLiVE

Sandoz targets digital therapeutics

Partners with Pear Therapeutics to launch FDA-approved apps

- PMLiVE

NHS England’s Simon Stevens – no Trump drug price rhetoric here

Health service supremo will play major role in UK pricing talks

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links